Institut de Myologie

Paris 75651

1 studies enrolling now · 6 studies all time

What they study most

Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD), Dysferlinopathy, Facioscapulohumeral Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy (FSHD), LGMD2B Now Classified as LGMDR2, Miyoshi Myopathy, Myotonic Dystrophy Type 1 (DM1), Spinal Muscular Atrophy

Studies at this site

• Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 — Recruiting now
• Confirmatory Study of Govorestat in CMT-SORD — Withdrawn before enrolling
• Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD — Running, not enrolling
• Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy — Completed
• Clinical Outcome Study for Dysferlinopathy — Status unconfirmed
• A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy — Stopped early